Navigation Links
Thoratec Reports 44 Percent Increase in Third Quarter Revenues
Date:10/30/2008

1,512 964 4,747 5,068

- Research and

development 592 481 1,936 1,870

Amortization of

purchased

intangibles 3,295 3,143 9,887 9,439

Make-whole

provision -(B) (11) - (91)

Income tax effect

of non-GAAP

adjustments (2,493) (1,162) (6,925) (5,027)

Net income on a

non-GAAP basis $10,459 $2,463 $27,111 $12,022

Diluted net income Three Months Ended Nine Months Ended

(loss) per share September 27, September 29, September 27, September 29,

reconciliation 2008 2007 2008 2007

(in thousands,

except per share

data)

Diluted net income

(loss) per share on

a GAAP basis $0.12 $(0.03) $0.28 $(0.01)

Share-based

compensation

expense:

- Cost of product

sales 0.01 0.01 0.02 0.02

Share-based

compensation

expense:

- Selling, general

and

administrative 0.02 0.02 0.08 0.09

- Research and

development 0.01 0.01 0.03 0.03

Amortization of

purchased

intangibles 0.05 0.05 0.16 0.18

Make-whole

provision - - - -

Income tax effect

of non-GAAP

adjustments (0.04) (0.02) (0.12) (0.09)

Convertible debt

dilution impact -(A) -(A) -(A)

Diluted net income

per share on a

non-GAAP basis $0.17 $0.04
'/>"/>

SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Thoratec Schedules Third Quarter 2008 Conference Call, Webcast
2. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
3. Thoratec Presentation at JP Morgan Conference to be Webcast
4. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
5. Thoratec Presentation at Bear Stearns Conference To Be Webcast
6. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
7. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
8. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
9. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
10. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
11. United Therapeutics Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- Research and Markets ( ... PharmaBiotech,s new report "Biomarkers - Technologies, Markets ... This report follows the broad definition of a ... measured and evaluated as an indicator of normal ... responses to a therapeutic intervention. Tests based on ...
(Date:9/2/2015)... ... September 02, 2015 , ... Drug ... plant-derived compounds. BCC Research reveals in its new report that the U.S. ... defines the category and generates the most market demand. , BCC Research ...
(Date:9/2/2015)... 2015 Veracyte, Inc. (NASDAQ: VCYT ) ... and chief executive officer, will present at the Morgan ... at 10:30 a.m. ET in New York, ... webcast and subsequent replay may be accessed by visiting Veracyte,s website ... shortly after conclusion of the presentation and archived on ...
(Date:9/2/2015)... ... September 02, 2015 , ... Advancing in medical imaging processing ... sign monitoring in ICU to 3D skull printing analysis for Neurosurgery, ONYX ZEUS ... decisions with simultaneous access to high precision medical images and electronic health records. ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3
... , ST. LOUIS, Sept. 15 ... the UBS Global Life Sciences Conference on Monday, September 21st at ... may listen via live audio broadcast over the Internet available at ... to access this file. , , ...
... CLARKSVILLE, Md.., Sept. 15 Ne u r ona s ... a privately-held biotechnology company developing novel, neurogenic small-molecule drugs for the treatment of depression, ... Scientific Officer, will present at the Life Sciences Summit 2009 -- S h ... Inno v ation, Pr o m ...
... , , HARTFORD, Conn., ... today announced the award of a 3-year Phase II Small ... entitled MRI DNA Biomarkers for Neuropsychiatric Disease, was awarded by ... In announcing the award, Gualberto Ruano, M.D., Ph.D., President/CEO ...
Cached Biology Technology:Neuronascent to Present at Life Sciences Summit 2009 2Genomas Awarded $1.4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness 2
(Date:8/28/2015)... 28, 2015 According to a ... by Assessment Type (Pen & Paper Based, Hosted, Biometrics), ... Learning, Academic Research), Vertical and Region - Global Forecast ... Market to grow from USD 2.4 Billion in 2015 ... Annual Growth Rate (CAGR) of 25.6% from 2015 to ...
(Date:8/24/2015)... Aug. 24, 2015  Based on its recent analysis of ... the 2015 African Biometrics Company of the Year Award. DERMALOG ... commercial success in Africa . It has ... it has implemented one of the largest biometric mass applications ... as the Central Bank of Nigeria ...
(Date:8/19/2015)... N.Y. , Aug. 19, 2015  VOXX ... that it has entered into a Definitive Agreement ... property, of iris authentication market leader EyeLock through ... VOXX will have a controlling interest in the ... subject to completion of due diligence.  Expanding on ...
Breaking Biology News(10 mins):Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
... living cell needs both to build new and to ... number of intracellular systems work in concert to keep ... proteins. When proteins or peptides mutate, they can present ... environment. In Huntington's disease (HD) the disease provoking mutation ...
... international group of scientists has announced a major ... the activities of genes in living organisms. ... to describe the complex events that occur when ... Understanding these events is crucial for developing new ...
... they won't be able to understand the brain until they ... billions of neurons are interconnected. Now, researchers at the Salk ... be a major hurdle to preparing that chart: identifying all ... March 1 issue of the journal Neuron, the researchers describe ...
Cached Biology News:Proteasome activator enhances survival of Huntington's disease neuronal model cells 2Uniform language for describing genes of pathogenic and beneficial microbes 2Uniform language for describing genes of pathogenic and beneficial microbes 3Deconstructing brain wiring, one neuron at a time 2Deconstructing brain wiring, one neuron at a time 3
Human peripheral blood basophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
... HT96 Isothermal Block is an anodized aluminum, ... plates and to provide efficient thermal transfer ... new design of the HT96 Isothermal Block ... enhanced product design allowing for compatibility with ...
...
Biology Products: